Trial NCT02521870

View at ClinicalTrials.gov 
Org. Study IDs: DV3-MEL-01
Secondary IDs: Keynote 184 SYNERGY-001

Last trial update was posted on 2021-08-03

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Head and Neck Neoplasms Melanoma Squamous Cell Carcinoma of Head and Neck

Other Conditions

Head Neck Cancer Metastatic Melanoma

Stopping Reasons

A strategic restructuring including the planned conclusion of clinical oncology development programs and no further sponsoring of the development of SD-101.

Limitations And Caveats

The sponsor terminated the trial early due to strategic restructuring, including the planned conclusion of clinical oncology development programs and no further sponsoring of the development of SD-101.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID